Global structure comprising 60 subsidiaries and 3 affiliates
First written in FY2016. 1 of 9 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 80 consolidated subsidiaries and 2 associates and other entities. Its principal businesses are the development, manufacture, sale, servicing, import and export of in-vitro diagnostic instruments and reagents, primarily for the medical sector.」
The number of consolidated subsidiaries increased from 78 in the previous disclosure to 80, while associates and other entities numbered 2. - 2026-05-29OtherGeneral Meetings of Shareholders
「Number of subsidiaries 80 companies」
The company disclosed 80 consolidated subsidiaries as of 31 March 2026. This was an increase from the 77 and 78 subsidiaries reported in the most recent annual securities reports. - FY2024Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 78 consolidated subsidiaries and 2 associates and other entities. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The number of consolidated subsidiaries increased from 77 to 78, while associates and other entities numbered 2. - FY2023Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 77 consolidated subsidiaries and 2 associates and other entities. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The number of consolidated subsidiaries increased from 76 in the previous disclosure to 77, while associates and other entities numbered 2. - FY2021RestatedAnnual report
「The Group comprises SYSMEX CORPORATION, 76 consolidated subsidiaries and 2 associates and other entities. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The composition of 76 consolidated subsidiaries and 2 associates and other entities has been reiterated. - FY2020Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 76 consolidated subsidiaries and 2 associates and other entities. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The number of consolidated subsidiaries increased from 73 to 76, while associates and other entities increased from 1 to 2. - FY2018Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 73 consolidated subsidiaries and 1 associate and other entity. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The Group structure has been updated from 62 consolidated subsidiaries and 2 associates and other entities to 73 consolidated subsidiaries and 1 associate and other entity. - FY2017Updated the number of Group companiesAnnual report
「The Group comprises SYSMEX CORPORATION, 62 consolidated subsidiaries and 2 associates and other entities. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
The Group structure has been updated from 60 subsidiaries and 3 associates to 62 consolidated subsidiaries and 2 associates and other entities. - FY2016First statedAnnual report
「The Group comprises SYSMEX CORPORATION, 60 subsidiaries and 3 associates. Its principal business is the healthcare business, which provides products and related services associated with in-vitro diagnostic testing.」
A structural fact showing the Group’s business composition and principal business.